447 related articles for article (PubMed ID: 29417249)
1. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.
van der Molen AJ; Reimer P; Dekkers IA; Bongartz G; Bellin MF; Bertolotto M; Clement O; Heinz-Peer G; Stacul F; Webb JAW; Thomsen HS
Eur Radiol; 2018 Jul; 28(7):2856-2869. PubMed ID: 29417249
[TBL] [Abstract][Full Text] [Related]
2. Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.
van der Molen AJ; Reimer P; Dekkers IA; Bongartz G; Bellin MF; Bertolotto M; Clement O; Heinz-Peer G; Stacul F; Webb JAW; Thomsen HS
Eur Radiol; 2018 Jul; 28(7):2845-2855. PubMed ID: 29426991
[TBL] [Abstract][Full Text] [Related]
3. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.
Stacul F; van der Molen AJ; Reimer P; Webb JA; Thomsen HS; Morcos SK; Almén T; Aspelin P; Bellin MF; Clement O; Heinz-Peer G;
Eur Radiol; 2011 Dec; 21(12):2527-41. PubMed ID: 21866433
[TBL] [Abstract][Full Text] [Related]
4. Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines.
Nyman U; Ahlkvist J; Aspelin P; Brismar T; Frid A; Hellström M; Liss P; Sterner G; Leander P;
Eur Radiol; 2018 Dec; 28(12):5384-5395. PubMed ID: 30132106
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravenous hydration in preventing post-contrast acute kidney injury in patients with eGFR < 30 mL/min/1.73 m
Yan P; Duan SB; Luo XQ; Zhang NY; Deng YH
Eur Radiol; 2023 Dec; 33(12):9434-9443. PubMed ID: 37368109
[TBL] [Abstract][Full Text] [Related]
6. Post-Contrast Acute Kidney Injury and Intravenous Prophylactic Hydration: An Update.
Nijssen EC; Rennenberg R; Nelemans P; van Ommen V; Wildberger JE
Rofo; 2021 Feb; 193(2):151-159. PubMed ID: 33327033
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of prophylactic hydration versus no hydration on contrast-induced acute kidney injury.
Jiang Y; Chen M; Zhang Y; Zhang N; Yang H; Yao J; Zhou Y
Coron Artery Dis; 2017 Dec; 28(8):649-657. PubMed ID: 28692484
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis against postcontrast acute kidney injury (PC-AKI): updates in the ESUR guidelines 10.0 and critical review.
Sebastià C; Nicolau C; Martín de Francisco ÁL; Poch E; Oleaga L
Radiologia (Engl Ed); 2020; 62(4):292-297. PubMed ID: 32029241
[TBL] [Abstract][Full Text] [Related]
9. Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines.
Stacul F; Bertolotto M; Thomsen HS; Pozzato G; Ugolini D; Bellin MF; Bongartz G; Clement O; Heinz-Peer G; van der Molen A; Reimer P; Webb JAW;
Eur Radiol; 2018 Feb; 28(2):683-691. PubMed ID: 28856420
[TBL] [Abstract][Full Text] [Related]
10. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines.
Thomsen HS; Morcos SK
Br J Radiol; 2003 Aug; 76(908):513-8. PubMed ID: 12893691
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
[TBL] [Abstract][Full Text] [Related]
12. Minimal risk of contrast-induced kidney injury in a randomly selected cohort with mildly reduced GFR.
Carlqvist J; Nyman U; Sterner G; Brandberg J; Fagman E; Hellström M
Eur Radiol; 2021 May; 31(5):3248-3257. PubMed ID: 33155105
[TBL] [Abstract][Full Text] [Related]
13. Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.
Keach JW; Stanislawski MA; Barón AE; Plomondon ME; Langner P; Amin A; Gilmartin HM; Waldo S; Maddox TM
BMC Nephrol; 2020 Apr; 21(1):150. PubMed ID: 32345254
[TBL] [Abstract][Full Text] [Related]
14. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.
Benko A; Fraser-Hill M; Magner P; Capusten B; Barrett B; Myers A; Owen RJ;
Can Assoc Radiol J; 2007 Apr; 58(2):79-87. PubMed ID: 17521052
[TBL] [Abstract][Full Text] [Related]
15. Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Yu Q; Zhu JJ; Liu WX
BMC Cardiovasc Disord; 2020 Apr; 20(1):187. PubMed ID: 32316910
[TBL] [Abstract][Full Text] [Related]
16. Impact on clinical practice of updated guidelines on iodinated contrast material: CINART.
Nijssen EC; Nelemans PJ; Rennenberg RJ; van der Molen AJ; van Ommen GV; Wildberger JE
Eur Radiol; 2020 Jul; 30(7):4005-4013. PubMed ID: 32107605
[TBL] [Abstract][Full Text] [Related]
17. Adherence to guidelines aimed at preventing post-contrast acute kidney injury (PC-AKI) in radiology practices: a survey study.
Dekkers IA; Olchowy C; Thomsen HS; Molen AJV
Acta Radiol; 2021 Jul; 62(7):979-984. PubMed ID: 32757641
[TBL] [Abstract][Full Text] [Related]
18. Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systematic review and meta-analysis.
Kao TW; Lee KH; Chan WP; Fan KC; Liu CW; Huang YC
Eur Radiol; 2022 May; 32(5):3045-3055. PubMed ID: 34837099
[TBL] [Abstract][Full Text] [Related]
19. Kidney and contrast media: Common viewpoint of the French Nephrology societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelines.
de Laforcade L; Bobot M; Bellin MF; Clément O; Grangé S; Grenier N; Wynckel A; Guerrot D
Diagn Interv Imaging; 2021 Mar; 102(3):131-139. PubMed ID: 33531265
[TBL] [Abstract][Full Text] [Related]
20. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
